Continuing semaglutide treatment is still recommended as it will likely allow weight loss to resume over time
The American Diabetes Association Standards of Care emphasize individualized treatment approaches, and medication adjustments should balance glycemic control or weight management goals with tolerability and quality of life considerations
Ozempic is goedgekeurd voor deze indicatie in de VS, EU, Canada, Japan en Australi2,3,4,5,6
Always remember that individual outcomes with the medication could vary, and some may experience different metabolic effects
And actually, for a while, I was thinking a lot about how long people were taking the drug, retention after one year, it was usually about 50% or something like that after prescription